VARIABILITY OF TG / HDL C RATIO IN NAFLD
Received
12 January 2024
Revised
-
Accepted
16 February 2024
Available Online
15 March 2024
Abstract
NAFLD IS A LEADING CAUSE OF CHRONIC LIVER DISEASE AS WELL AS A LEADING CAUSE OF LIVER MORBIDITY AND MORT ALITY. ELEVATED SERUM TRIGLYCERIDES AND LOW SERUM HDL CHOLESTEROL ARE COMMON IN METABOLIC SYNDROME AND THE TRIGLYCERIDE / HDL CHOLESTEROL (TG / HDL C) RATIO HAS BEEN SHOWN TO BE A PREDICTOR OF INSULIN RESISTANCE, TYPE 2 DIABETES, HYPERTENSION, AND CARDIOVASCULAR DISEASE. LIMITED CURRENT DATA SUGGEST SIGNIFICANT CORRELATION OF TG / HDL C RATIO WITH NAFLD. THE OBJECTIVE OF THE PRESENT STUDY IS TO HIGHLIGHT THE CLINICAL SIGNIFICANCE OF THE VARIABILITY OF THE TRIGLYCERIDE / HDL CHOLESTEROL RATIO IN NAFLD.
Keywords
TRYGLICERIDES
HDL CHOLESTEROL
NAFLD
TG / HDL C RATIO
Full Text
The body of this article is intentionally hidden on the public page. Please use the PDF reader or the PDF download for the complete text.
References
[1]
Ivana Semova and Sudha B. Biddinger . Triglycerides in NAFLD: Guilty until proven innocent. Trends Pharmacol Sci. 2021 Mar; 42(3): 183 - 190.
[2]
Lu S, Xie Q, Kuang M, Hu C, Li X, Yang H, Sheng G, Xie G, Zou Y. Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis. J Transl Med. 2023 Mar 13; 21(1):192.
[3]
Menno Hoekstra , Miranda Van Eck . High-density lipoproteins and non -alcoholic fatty liver disease. Atheroscler Plus. 2023 Aug 19: 53:33-41.
[4]
Arthur McCullough et al. HDL flux is higher in patients with nonalcoholic fatty liver disease. Am J Physiol Endocrinol Metab. 2019 Nov 1; 317(5): E852 - E862.
[5]
Roberto Catanzaro et al. Triglycerides to high -density lipoprotein cholesterol ratio for diagnosing nonalcoholic fatty liver disease. Minerva Gastroenterol (Torino). 2022 Sep; 68(3): 261 - 268.
[6]
Guqiao Nie et al. High TG/HDL ratio suggests a higher risk of metabolic syndrome among an elderly Chinese population: a crosssectional study. BMJ Open 2021;11:e041519.
[7]
Luciana Nicolau Aranha. TG/HDL-c Ratio as a Predictor of Cardiovascular Risk. Int J Cardiovasc Sci. 2021; 34(5Supl.1): 66-67.
[8]
Hyun-Gyu Shin et al. The Relationship between the Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Metabolic Syndrome. Korean J Fam Med. 2017 Nov; 38(6): 352 - 357.
[9]
Girona J et al. HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk. Int J Mol Sci. 2019 Jun 27; 20(13):3151.
[10]
Danilo Neglia et al. The triglyceride HDL cholesterol ratio: an independent predictor of obstructive coronary artery disease and myocardial ischemia in patients with chronic coronary syndrome. Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1671.
[11]
Medical News Today - How to calculate cholesterol ratios.
[12]
12. Jun-Xiang Xia et al. Application of TG/HDL -C Combined with Liver Function Indexes to Predict Metabolic-Associated Fatty Liver Disease. Sichuan Da Xue Xue Bao Yi Xue Ban . 2022 Sep;5 3(5):764 - 769.
[13]
Nengguang Fan et al. Triglycerides to high -density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study. Lipids Health Dis. 2019 Feb 2; 18(1):39.
[14]
Riazi K., Azhari H., Charette J.H., Underwood F.E., King J.A., Afshar E.E., Swain M.G., Congly S.E., Kaplan G.G., Shaheen A.A. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022; 7(9):851 - 861.
[15]
Borrayo G et al. TG/HDL-C Ratio as cardio -metabolic biomarker even in normal weight women. Acta Endocrinol (Buchar). 2018 Apr-Jun; 14(2): 261 - 267.
[16]
Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023 Apr 1;77(4):1335-1347.
[17]
Kim-Dorner SJ et al. Should triglycerides and the triglycerides to high -density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? Metabolism 2010; 59: 299 - 304.
[18]
Lu S, Kuang M, Yue J, Hu C, Sheng G, Zou Y. Utility of traditional and non -traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population. Lipids Health Dis. 2022 Oct 7; 21(1):95.
[19]
Cosentino, F. et al. ESC/EASD guidelines on diabetes, pre -diabetes, and cardiovascular diseases. Eur. Heart J. 2020(41), 25 - 323.
[20]
Luis A. Rodriguez et al. Predicting Non -Alcoholic Fatty Liver Disease for Adults Using Practical Clinical Measures: Evidence from the Multi -ethnic Study of Atherosclerosis. Journal of General Internal Medicine volume 36, pages 2648 - 2655 (2021).
[21]
Luis A. Rodriguez et al. Predicting Non -Alcoholic Fatty Liver Disease for Adults Using Practical Clinical Measures: Evidence from the Multi -ethnic Study of Atherosclerosis. Journal of General Internal Medicine volume 36, pages 2648 - 2655 (2021).
[22]
Murgurìa-Romero, M. et al. Plasma triglyceride/HDL -cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults. J. Lipid Res. 2013, 54, 2795 - 2799.
[23]
Murgurìa-Romero, M. et al. Plasma triglyceride/HDL -cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults. J. Lipid Res. 2013, 54, 2795 - 2799.
[24]
Qurat ul Ain et al. Triglycerides-to-HDLC Ratio as a Marker of Cardiac Disease andVascular Risk Factors in Adults. J Coll Physicians Surg Pak 2019; 29(11):1034 - 7. Notes: • This research has not received any specific funding or grants from public, commercial, or non-profit funding agencies. • The authors declare that there are no conflicts of interest in the preparation of this article.